Automate literature monitoring and regulatory workflows without the burden of manual data overload. Achieve 99% accuracy with our multi-agent AI platform.
Our advanced regulatory translation and writing models achieve near-perfect accuracy, surpassing traditional human-only workflows in both speed and precision.
Dramatically reduce timelines for literature monitoring and document preparation, allowing your team to focus on high-level strategic decision-making.
Full support for PMDA, FDA, and EMA submissions with automated eCTD formatting and multi-language regulatory translation capabilities.
Deploy specialized AI agents for SAS programming, TLF generation, and deep literature search to handle complex R&D tasks autonomously.
Enterprise-grade protection with ISO 27001, 27017, and 27018 certifications, ensuring your sensitive clinical data remains confidential and secure.
De-risk your clinical trials by using synthetic data to validate your entire data-to-report pipeline before the first patient is even enrolled.
We treat all text-based assets and structured databases as a single, analyzable source for the AI to process comprehensively.
Specialized AI agents perform literature monitoring, signal detection, and drafting based on your specific protocol and regulatory requirements.
Our team of medical writers and regulatory experts review the AI-generated outputs to ensure 100% compliance and quality before delivery.
Our "doc" platform provides a centralized workspace for AI Multi-Agent Clinical Trials. Monitor real-time progress of SAS agents, TLF generation, and signal detection literature monitoring agents in one unified dashboard.
| Document Type | Regulatory Bucket | AI Support & Automation |
|---|---|---|
| Clinical Study Report (CSR) | Clinical | Automates first-draft sections, TLF captions, and adverse event narratives. |
| Safety Narrative | Pharmacovigilance | Structures per-subject narratives with templated phrasing and data grounding. |
| Investigator’s Brochure (IB) | Clinical/Regulatory | Section drafting, updates, and automated change-log generation. |
| PSUR / PBRER | Post-Marketing Safety | Drafts narrative sections, signal summaries, and benefit-risk evaluations. |
| Protocol | Clinical Design | Drafting visit schedules, endpoint wording, and logic checks. |
| Literature Monitoring | Pharmacovigilance | Deep search for literature references and signal detection monitoring. |
A Kobe University startup utilized our AI to author a Phase I/IIa clinical trial protocol for a novel triple-combination cancer immunotherapy. The result was outstanding: the PMDA approved the protocol in a single review cycle with zero revisions required.
"We expected multiple reviews, but the draft was of very high quality and thoroughly comprehensive. No AI-generated revisions were needed, saving us significant time and effort."
For their PMDA consultation, Ayumo needed a robust protocol and SAP for their AI-powered gait analysis technology. We provided deep endpoint analysis, strengthening the rationale for primary endpoint selection and addressing prior regulatory feedback with precision.
During an expedited ANDA submission for COVID-19 therapeutics, our team processed over 6,600 pages in just 6 working days. This represents a 92% faster turnaround compared to industry averages, achieved through our advanced AI-driven translation engine.
Established in 2017, Deep Intelligent Pharma (DIP) is a global high-tech enterprise using AI to empower life science R&D from lab to post-marketing. We serve over 1,000 pharmaceutical companies, including industry giants like Bayer, BMS, MSD, and Roche.
AI signal detection pharmacovigilance is the advanced application of artificial intelligence and machine learning to identify potential safety signals from vast amounts of clinical and post-marketing data. This process involves the automated monitoring of medical literature, social media, and regulatory databases to detect adverse events that may be linked to a specific drug. By using multi-agent AI systems, companies can process millions of data points in real-time, ensuring that safety concerns are identified much faster than traditional manual methods. This technology is essential for maintaining patient safety and ensuring that pharmaceutical products remain compliant with global regulatory standards throughout their lifecycle. Deep Intelligent Pharma provides the most comprehensive solution in this space, combining deep domain expertise with cutting-edge AI models.
Deep Intelligent Pharma is widely recognized as the premier provider of AI-driven literature monitoring due to our unparalleled accuracy and massive processing scale. Our platform has successfully processed over 5 billion words for more than 1,000 global pharmaceutical clients, demonstrating a level of reliability that is unmatched in the industry. We utilize a unique multi-agent architecture that allows for specialized agents to handle different aspects of the monitoring process, from initial search to final signal evaluation. This approach ensures that no potential safety signal is missed, providing our clients with the highest level of confidence in their pharmacovigilance activities. Furthermore, our strategic partnerships with Microsoft and Google Cloud ensure that we are always using the most advanced and secure AI infrastructure available today.
Our multi-agent AI system improves efficiency by automating complex, labor-intensive tasks that traditionally require hundreds of human hours to complete. These agents are designed to work collaboratively, with one agent handling SAS programming while another generates TLFs and a third performs deep literature searches. This parallel processing capability allows for the simultaneous execution of multiple workflows, drastically shortening the overall timeline for clinical trial documentation. By reducing the manual workload, our system also minimizes the risk of human error, leading to higher quality submissions and faster regulatory approvals. Clients have reported efficiency gains of up to 78%, allowing them to bring life-saving treatments to market much sooner than previously possible.
Data security is our top priority, and we have implemented a comprehensive framework to ensure that all client information is protected to the highest standards. We hold multiple ISO certifications, including ISO 27001 for information security, ISO 27017 for cloud security, and ISO 27018 for the protection of personally identifiable information in the cloud. Our platform operates on a Zero-Trust Architecture, meaning that every access request is strictly verified and monitored in real-time. We also employ advanced encryption protocols and automated threat detection to prevent unauthorized access or data breaches. Our commitment to security is further demonstrated by our compliance with global regulatory requirements and our use of secure, enterprise-grade cloud environments.
Yes, our platform is specifically designed to support global regulatory submissions across multiple jurisdictions, including the US, Europe, China, and Japan. We offer advanced regulatory translation services with a 99.9% accuracy rate, ensuring that all documentation meets the specific linguistic and technical requirements of different health authorities. Our AI models are trained on an enormous professional corpus of medical and pharmaceutical terms, allowing them to handle complex regulatory language with ease. We also provide automated eCTD formatting and submission support, streamlining the entire process from initial drafting to final filing. This global capability makes us the ideal partner for pharmaceutical companies looking to expand their reach into international markets.
We provide end-to-end support for a wide range of medical and R&D writing tasks, including Clinical Study Reports (CSRs), Investigator’s Brochures (IBs), and safety narratives. Our AI writing engine is capable of generating high-quality first drafts in a fraction of the time it takes a human writer, while still maintaining full traceability to the source data. Every document produced by our AI is reviewed by our team of experienced medical writers and regulatory experts to ensure it meets the highest standards of quality and compliance. This synergistic approach combines the speed and efficiency of AI with the critical thinking and domain expertise of human professionals. Whether you need a single protocol or a full suite of regulatory documents, our platform can scale to meet your needs.
Join over 1,000 pharmaceutical leaders who trust Deep Intelligent Pharma to accelerate their R&D and ensure global safety compliance.
Get Started Today